Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates
1990
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Facioscapulohumeral muscular dystrophy: Evidence for selective, genetic electrophysiologic cardiac involvement
1990
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Out-of-Hospital Transcutaneous Pacing by Emergency Medical Technicians in Patients with Asystolic Cardiac Arrest
1993
The metabolic syndrome
2010 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing☆
2004
Systemic sclerosis
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Primary pulmonary hypertension
1988
Alcohol and Risk of Atrial Fibrillation or Flutter
2004
Primary Pulmonary Hypertension
1997 Standout
Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation
2017
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
2006
The MUSTT Study: Evaluating Testing and Treatment
2000
Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing
1988
Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation
2001
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
1990
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by n-3 Polyunsaturated Fatty Acids in Dogs
2007
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Gonococcal Endocarditis: Twenty-Five Year Experience
1991
Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases
1989 Standout
A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation
2008
Sudden arrhythmic cardiac death—Mechanisms, resuscitation and classification: The seattle perspective
1990
Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening
1991
Hypertrophic Cardiomyopathy
2002 Standout
Clinical Performance of the Implantable Cardioverter Defibrillator: Electrocardiographic Documentation of 101 Spontaneous Discharges
1991
Conventional heart rate variability analysis of ambulatory electrocardiographiic recording fails to predict imminent ventricular fibrillation
1993
Autonomic Control of Cardiovascular Function: Clinical Evaluation in Health and Disease
1994
Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction
1990
Incidence and Prognosis of Syncope
2002 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Clinical Subtypes of Lone Atrial Fibrillation
2005
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*
2009
Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.
2002
Ventricular Arrhythmia Factors in Mitral Valve Prolapse
1994
Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
1998
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study
1989
Spontaneous Intracerebral Hemorrhage
2001 Standout
Myocarditis
2009 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Electrophysiologic testing in bundle branch block and unexplained syncope
1984
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association.
1991 Standout
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.
1989
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Myocarditis
2006 Standout
Silent Myocardial Ischemia as a Mechanism of Sudden Cardiac Death
1986
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Significance of inducible tachycardia in patients with syncope of unknown origin: A long-term follow-up
1985
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
1999
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council.
1991 Standout
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Sudden Cardiac Death
1998 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern.
1990
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy
2015
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States
2011
Alcohol and stroke.
1987
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest
1985
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Harmonizing the Metabolic Syndrome
2009 Standout
Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction.
1986
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring
1987
Heart Rate Variability
1996 Standout
Relation between the widening of the fragmented atrial activity zone and atrial fibrillation
1983
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
2009
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Works of Jerry C. Luck being referenced
Acute Myocarditis in Fulminant Systemic Sclerosis
1992
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Termination of sustained ventricular tachycardia by external noninvasive pacing
1988
Complications of biventricular pacing
2003
Proarrhythmia
2001
A Review of Clinical Trials Assessing the Efficacy and Safety of Newer Antiarrhythmic Drugs in Atrial Fibrillation
2003
Atrial fibrillation in patients with heart failure
2003
Arrhythmias in patients with heart failure
2002
Amiodarone: clinical trials
2000
Atrial Fibrillation in Heart Failure:
2003
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy
2000
Induction of clinical ventricular tachycardia using programmed stimulation: Value of third and fourth extrastimuli
1983
Effect of bradycardia on dispersion of ventricular refractoriness
1985
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
Permanent triggered antitachycardia pacemakers in the management of recurrent sustained ventricular tachycardia
1985
Rapid Attenuation of Response to Nifedipine in Primary Pulmonary Hypertension
1982
Gonococcal endocarditis: A case series demonstrating modern presentation of an old disease
1984
Effect of whiskey on atrial vulnerability and “holiday heart”
1983
Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events
1983
Effect of increased current, multiple pacing sites and number of extrastimuli on induction of ventricular tachycardia
1986
Prospective comparison of right and left ventricular stimulation for induction of sustained ventricular tachycardia
1987
Modification of ventricular tachycardia by procainamide in patients with coronary artery disease
1980
Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads
2013
Conduction system abnormalities in symptomatic mitral valve prolapse: An electrophysiologic analysis of 60 patients
1984
Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care
1999
Diagnostic Implications of Atrial Vulnerability*
1979